Hospira gets FDA warning letter for Italian facility
April 07, 2015 at 11:12 AM EDT
April 7 (Reuters) - Hospira Inc, which agreed in February to be acquired by Pfizer Inc, said it received a warning letter from the U.S. Food and Drug Administration related to its manufacturing facility in Liscate, Italy.